Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Tax Provisions (2018 - 2020)

Acro Biomedical has reported Tax Provisions over the past 3 years, most recently at -$18092.0 for Q4 2020.

  • Quarterly results put Tax Provisions at -$18092.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Sep 2021 was -$18092.0 (changed N/A YoY), and the annual figure for FY2020 was -$18092.0, up 65.95%.
  • Tax Provisions for Q4 2020 was -$18092.0 at Acro Biomedical, down from $9871.0 in the prior quarter.
  • Over the last five years, Tax Provisions for ACBM hit a ceiling of $59917.0 in Q2 2018 and a floor of -$45124.0 in Q1 2019.
  • Median Tax Provisions over the past 3 years was -$7063.0 (2018), compared with a mean of $133.0.
  • Peak annual rise in Tax Provisions hit 163.16% in 2019, while the deepest fall reached 258.0% in 2019.
  • Acro Biomedical's Tax Provisions stood at -$19941.0 in 2018, then surged by 149.5% to $9871.0 in 2019, then plummeted by 283.28% to -$18092.0 in 2020.
  • The last three reported values for Tax Provisions were -$18092.0 (Q4 2020), $9871.0 (Q3 2019), and -$17877.0 (Q2 2019) per Business Quant data.